Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1997-02-28
2000-02-01
Scheiner, Toni R.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 2431, 435 6, 435 691, 435346, C07H 2104, C12Q 168
Patent
active
060204788
ABSTRACT:
The present invention provides a human tumor-associated antigen (PRAT) and polynucleotides which identify and encode PRAT. In addition, the invention provides expression vectors and host cells, agonists, antibodies, and antagonists. The invention also provides methods for treating disorders associated with the expression of PRAT.
REFERENCES:
Database EMBL, European Bioinformatics Institute, Accession No. AA224827, Feb. 22, 1997, Strausberg R.: "nc33c12.sl NCI.sub.- CGAP.sub.- Pr2 Homo sapiens cDNA clone", XP002071038.
Database Genbank, GenBank ACC. No.: H64488; Oct. 27, 1995, Hillier, L. et al.: "yu67a12.rl Homo sapiens cDNA clone 238846 5", XP002071139, WashU-Merck EST Project.
Hillier, et al., WashU-Merck EST Project, available Dec. 5, 1996, Genbank Accession No. AA146605.
The Molecular Biology of the Cell, Alberts et al., Garland Publishing, New York, 1983, pp. 398-400.
Helzlsouer, K.J., "Epidemiology, prevention, and early detection of breast cancer", Curr. Opin. Oncol., 6: 541-548 (1994).
Harris, J.R. et al, "Breast cancer", New England J. Med, 327: 319-328 (1992).
Minegishi, M. et al., "Monoclonal antibody directed to human T-cell malignancy antigen", Leuk Res, 13:43-51 (1989).
Tagaki, S., "Identification of a highly specific surface marker of T-cell acute lymphoblastic leukemia and neuroblastoma as a new member of the transmembrane 4 superfamily", Int. J. Cancer, 61: 706-715 (1995).
Lui, E. et al., "The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast", Oncogene, 7: 1027-1032 (1992).
Kern, J.A., et al., "Inhibition of Human Lung Cancer Cell Line Growth by an Anti-p185.sup.HER2 Antibody", Am J Respir Cell Mol Biol, 9:448-454 (1993).
Imai, T. et al., "C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD4 or CD8 in T cells", J. Immunol., 151: 6470-6481 (1993).
Hotta, H. et al., "Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression", Cancer Res., 48: 2955-2962 (1988).
Classon, B.J. et al., "The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen", J. Exp. Med, 169: 1497-1502 (1989).
Tomlinson, M.G. et al., "Characterization of Mouse CD37: CDNA and genomic cloning", Mol. Immunol., 33: 867-872 (1996).
Szala, S. et al., "Molecular cloning of cDNA for the human tumor-associated antigen CO-029 and identification of related transmembrane antigens", Proc. Natl. Acad. Sci., 87: 6833-3837 (1990).
Goli Surya K.
Hillman Jennifer L.
Zhang Hong
Incyte Pharmaceuticals Inc.
Scheiner Toni R.
Streeter David G.
LandOfFree
Human tumor-associated antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human tumor-associated antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human tumor-associated antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-938754